Skip to content

Popularize referral program for neuroblastoma in children

Popularize referral program for neuroblastoma in children and effect evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024320
Enrollment
Unknown
Registered
2019-07-06
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroblastoma

Interventions

Referral group:Referral
control group:N/A

Sponsors

National Center for Children's Health, Capital Medica University, Beijing Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Infants younger than 1 year old: 1. Cough for more than one month, Excluding Pulmonary Infection; 2. Myoclonus ocular clonus; 3. Intractable Diarrhea; 4. Masses or skin nodules found in the abdomen or chest. Children aged 1-5 years have one or more of the following situations: 1. Fever and anemia of unknown origin; 2. Extensive lymphadenopathy; 3. Unexplained limb pain; 4. Pallor, fatigue, emaciation, irritability, sweating, loss of appetite; 5. Abdominal pain or diarrhea; 6. Dysfunction of limbs; 7. Ocular manifestations (unilateral exophthalmos, periorbital ecchymosis, nystagmus); 8. Unexplained bruises.

Exclusion criteria

Exclusion criteria: 1. Parents disagree with screening; 2. Have congenital disease such as congenital hereditary metabolic disease ,congenital monstrosity, dysgnosia; 3. have history of malignant disease.

Design outcomes

Primary

MeasureTime frame
Onset age;

Secondary

MeasureTime frame
Stage;2-year survival;

Countries

China

Contacts

Public ContactXiaoli Ma

National Center for Children's Health, Capital Medica University, Beijing Children's Hospital

mxl1123@vip.sina.com+86 010 59617612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026